Use of a fluoropolymer-based paclitaxel-eluting stent for arteriovenous graft outflow vein stenosis in hemodialysis patients

We implanted a fluoropolymer-based paclitaxel-eluting stent (FP-PES) in four hemodialysis patients with refractory outflow venous stenosis of their arteriovenous graft. The mean observation period after FP-PES implantation was 11.5 ± 4.7 months (range, 7.0-18.0 months). After FP-PES implantation, th...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yuki Matsuoka, MD, MBA, Osamu Iida, MD, Kotaro Suemitsu, MD, PhD, Kanako Oka, MD, Naomi Ota, MD, Masaaki Izumi, MD, PhD
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2021-06-01
coleção:	Journal of Vascular Surgery Cases and Innovative Techniques
Assuntos:	Arteriovenous shunt Drug-eluting stents Hemodialysis Paclitaxel Stenosis
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S246842872100054X
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!